nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—CREB1—sarcoma	0.00268	0.0117	CbGpPWpGaD
Acamprosate—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.00263	0.0115	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—CREB1—sarcoma	0.0026	0.0114	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.00254	0.0111	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.00248	0.0109	CbGpPWpGaD
Acamprosate—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.00245	0.0107	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.00239	0.0105	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—CREB1—sarcoma	0.00226	0.00991	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—CREB1—sarcoma	0.00221	0.00966	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.00209	0.00913	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.00203	0.0089	CbGpPWpGaD
Acamprosate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.00201	0.00879	CbGpPWpGaD
Acamprosate—GRIN2B—ErbB4 signaling events—MDM2—sarcoma	0.00191	0.00836	CbGpPWpGaD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00188	0.00821	CbGpPWpGaD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—CREB1—sarcoma	0.00184	0.00805	CbGpPWpGaD
Acamprosate—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.00175	0.00767	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00174	0.00763	CbGpPWpGaD
Acamprosate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—sarcoma	0.00171	0.00748	CbGpPWpGaD
Acamprosate—GRIN2C—Post NMDA receptor activation events—HRAS—sarcoma	0.00154	0.00676	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—PLCG1—sarcoma	0.00148	0.00649	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—PLCG1—sarcoma	0.00145	0.00633	CbGpPWpGaD
Acamprosate—GRIN2D—Post NMDA receptor activation events—HRAS—sarcoma	0.00144	0.00628	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00143	0.00627	CbGpPWpGaD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00142	0.00622	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCR4—sarcoma	0.00137	0.00599	CbGpPWpGaD
Acamprosate—GRIN1—EPHB-mediated forward signaling—SRC—sarcoma	0.00135	0.00589	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EZR—sarcoma	0.00134	0.00588	CbGpPWpGaD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00132	0.00579	CbGpPWpGaD
Acamprosate—GRIN2B—EPHB-mediated forward signaling—SRC—sarcoma	0.00131	0.00574	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EZR—sarcoma	0.00131	0.00574	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.0013	0.00569	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MYOG—sarcoma	0.00127	0.00554	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00125	0.00547	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MYOG—sarcoma	0.00123	0.0054	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—KDR—sarcoma	0.00122	0.00536	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—sarcoma	0.00122	0.00533	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—KDR—sarcoma	0.00119	0.00523	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—HRAS—sarcoma	0.00118	0.00516	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.00117	0.00513	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.00109	0.00477	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00109	0.00475	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—HRAS—sarcoma	0.00103	0.0045	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—HRAS—sarcoma	0.001	0.00439	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP2—sarcoma	0.001	0.00438	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PLCG1—sarcoma	0.000979	0.00428	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP2—sarcoma	0.000975	0.00427	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.00097	0.00425	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EZR—sarcoma	0.000959	0.0042	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000947	0.00414	CbGpPWpGaD
Acamprosate—GRIN1—EPHB-mediated forward signaling—HRAS—sarcoma	0.000947	0.00414	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EZR—sarcoma	0.000935	0.00409	CbGpPWpGaD
Acamprosate—GRIN2B—EPHB-mediated forward signaling—HRAS—sarcoma	0.000923	0.00404	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000923	0.00404	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Etoposide—sarcoma	0.000919	0.00119	CcSEcCtD
Acamprosate—Tachycardia—Etoposide—sarcoma	0.000916	0.00119	CcSEcCtD
Acamprosate—Eosinophilia—Epirubicin—sarcoma	0.000916	0.00119	CcSEcCtD
Acamprosate—Abdominal pain—Vincristine—sarcoma	0.000916	0.00119	CcSEcCtD
Acamprosate—Body temperature increased—Vincristine—sarcoma	0.000916	0.00119	CcSEcCtD
Acamprosate—Liver function test abnormal—Doxorubicin—sarcoma	0.000914	0.00119	CcSEcCtD
Acamprosate—Skin disorder—Etoposide—sarcoma	0.000912	0.00118	CcSEcCtD
Acamprosate—Dry skin—Doxorubicin—sarcoma	0.000908	0.00118	CcSEcCtD
Acamprosate—Hyperhidrosis—Etoposide—sarcoma	0.000907	0.00118	CcSEcCtD
Acamprosate—Pancreatitis—Epirubicin—sarcoma	0.000907	0.00118	CcSEcCtD
Acamprosate—Orthostatic hypotension—Doxorubicin—sarcoma	0.000905	0.00117	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000902	0.00395	CbGpPWpGaD
Acamprosate—Angina pectoris—Epirubicin—sarcoma	0.000901	0.00117	CcSEcCtD
Acamprosate—Urticaria—Mitoxantrone—sarcoma	0.000896	0.00116	CcSEcCtD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000895	0.00392	CbGpPWpGaD
Acamprosate—Breast disorder—Doxorubicin—sarcoma	0.000895	0.00116	CcSEcCtD
Acamprosate—Anorexia—Etoposide—sarcoma	0.000895	0.00116	CcSEcCtD
Acamprosate—Diarrhoea—Thiotepa—sarcoma	0.000894	0.00116	CcSEcCtD
Acamprosate—Abdominal pain—Mitoxantrone—sarcoma	0.000892	0.00116	CcSEcCtD
Acamprosate—Body temperature increased—Mitoxantrone—sarcoma	0.000892	0.00116	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000892	0.00116	CcSEcCtD
Acamprosate—Bronchitis—Epirubicin—sarcoma	0.00089	0.00115	CcSEcCtD
Acamprosate—Diarrhoea—Dactinomycin—sarcoma	0.000887	0.00115	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CREB1—sarcoma	0.000882	0.00386	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—sarcoma	0.00088	0.00385	CbGpPWpGaD
Acamprosate—Hypotension—Etoposide—sarcoma	0.000877	0.00114	CcSEcCtD
Acamprosate—Gastritis—Doxorubicin—sarcoma	0.000877	0.00114	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000874	0.00113	CcSEcCtD
Acamprosate—Dizziness—Thiotepa—sarcoma	0.000864	0.00112	CcSEcCtD
Acamprosate—Abdominal distension—Doxorubicin—sarcoma	0.000862	0.00112	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—sarcoma	0.000856	0.00111	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—sarcoma	0.000856	0.00111	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—sarcoma	0.000856	0.00111	CcSEcCtD
Acamprosate—Pollakiuria—Epirubicin—sarcoma	0.000855	0.00111	CcSEcCtD
Acamprosate—Hypersensitivity—Vincristine—sarcoma	0.000854	0.00111	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—sarcoma	0.000848	0.0011	CcSEcCtD
Acamprosate—Photosensitivity reaction—Epirubicin—sarcoma	0.000844	0.00109	CcSEcCtD
Acamprosate—Paraesthesia—Etoposide—sarcoma	0.000843	0.00109	CcSEcCtD
Acamprosate—Weight increased—Epirubicin—sarcoma	0.000842	0.00109	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—sarcoma	0.000839	0.00109	CcSEcCtD
Acamprosate—Weight decreased—Epirubicin—sarcoma	0.000837	0.00108	CcSEcCtD
Acamprosate—Dyspnoea—Etoposide—sarcoma	0.000837	0.00108	CcSEcCtD
Acamprosate—Hyperglycaemia—Epirubicin—sarcoma	0.000835	0.00108	CcSEcCtD
Acamprosate—Somnolence—Etoposide—sarcoma	0.000834	0.00108	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—sarcoma	0.000834	0.00108	CcSEcCtD
Acamprosate—Hypersensitivity—Mitoxantrone—sarcoma	0.000831	0.00108	CcSEcCtD
Acamprosate—Asthenia—Vincristine—sarcoma	0.000831	0.00108	CcSEcCtD
Acamprosate—Vomiting—Thiotepa—sarcoma	0.000831	0.00108	CcSEcCtD
Acamprosate—Pneumonia—Epirubicin—sarcoma	0.00083	0.00108	CcSEcCtD
Acamprosate—Vomiting—Dactinomycin—sarcoma	0.000825	0.00107	CcSEcCtD
Acamprosate—Rash—Thiotepa—sarcoma	0.000824	0.00107	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—sarcoma	0.000823	0.00107	CcSEcCtD
Acamprosate—Dermatitis—Thiotepa—sarcoma	0.000823	0.00107	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CREB1—sarcoma	0.00082	0.00359	CbGpPWpGaD
Acamprosate—Headache—Thiotepa—sarcoma	0.000819	0.00106	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—sarcoma	0.000818	0.00358	CbGpPWpGaD
Acamprosate—Rash—Dactinomycin—sarcoma	0.000818	0.00106	CcSEcCtD
Acamprosate—Decreased appetite—Etoposide—sarcoma	0.000816	0.00106	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Etoposide—sarcoma	0.00081	0.00105	CcSEcCtD
Acamprosate—Asthenia—Mitoxantrone—sarcoma	0.00081	0.00105	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000807	0.00353	CbGpPWpGaD
Acamprosate—Stomatitis—Epirubicin—sarcoma	0.000804	0.00104	CcSEcCtD
Acamprosate—Pain—Etoposide—sarcoma	0.000803	0.00104	CcSEcCtD
Acamprosate—Constipation—Etoposide—sarcoma	0.000803	0.00104	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—sarcoma	0.000802	0.00104	CcSEcCtD
Acamprosate—Diarrhoea—Vincristine—sarcoma	0.000793	0.00103	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PTPRC—sarcoma	0.000792	0.00347	CbGpPWpGaD
Acamprosate—Sweating—Epirubicin—sarcoma	0.000791	0.00103	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—sarcoma	0.000791	0.00102	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—sarcoma	0.000787	0.00102	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MYOD1—sarcoma	0.000782	0.00342	CbGpPWpGaD
Acamprosate—Photosensitivity reaction—Doxorubicin—sarcoma	0.000781	0.00101	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000781	0.00342	CbGpPWpGaD
Acamprosate—Weight increased—Doxorubicin—sarcoma	0.000779	0.00101	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—sarcoma	0.000778	0.00101	CcSEcCtD
Acamprosate—Nausea—Thiotepa—sarcoma	0.000776	0.00101	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PLCG1—sarcoma	0.000775	0.00339	CbGpPWpGaD
Acamprosate—Weight decreased—Doxorubicin—sarcoma	0.000774	0.001	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCR4—sarcoma	0.000774	0.00339	CbGpPWpGaD
Acamprosate—Feeling abnormal—Etoposide—sarcoma	0.000773	0.001	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—PTPRC—sarcoma	0.000772	0.00338	CbGpPWpGaD
Acamprosate—Hyperglycaemia—Doxorubicin—sarcoma	0.000772	0.001	CcSEcCtD
Acamprosate—Diarrhoea—Mitoxantrone—sarcoma	0.000772	0.001	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—sarcoma	0.00077	0.000998	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—sarcoma	0.000768	0.000995	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—sarcoma	0.000767	0.000995	CcSEcCtD
Acamprosate—Dizziness—Vincristine—sarcoma	0.000766	0.000993	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—CREB1—sarcoma	0.000763	0.00334	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MYOD1—sarcoma	0.000762	0.00334	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000761	0.00333	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PLCG1—sarcoma	0.000756	0.00331	CbGpPWpGaD
Acamprosate—Urticaria—Etoposide—sarcoma	0.000746	0.000966	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—sarcoma	0.000744	0.000965	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CREB1—sarcoma	0.000744	0.00326	CbGpPWpGaD
Acamprosate—Stomatitis—Doxorubicin—sarcoma	0.000744	0.000964	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—sarcoma	0.000742	0.000962	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—sarcoma	0.000742	0.000962	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—sarcoma	0.000742	0.000962	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—sarcoma	0.000742	0.000962	CcSEcCtD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000741	0.00324	CbGpPWpGaD
Acamprosate—Haemorrhage—Epirubicin—sarcoma	0.000741	0.00096	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—sarcoma	0.000741	0.00096	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—sarcoma	0.000737	0.000955	CcSEcCtD
Acamprosate—Vomiting—Vincristine—sarcoma	0.000737	0.000955	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000735	0.00322	CbGpPWpGaD
Acamprosate—Pharyngitis—Epirubicin—sarcoma	0.000735	0.000953	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—sarcoma	0.000732	0.000948	CcSEcCtD
Acamprosate—Rash—Vincristine—sarcoma	0.000731	0.000947	CcSEcCtD
Acamprosate—Dermatitis—Vincristine—sarcoma	0.00073	0.000946	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—sarcoma	0.00073	0.000946	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MDM2—sarcoma	0.000729	0.00319	CbGpPWpGaD
Acamprosate—Haematuria—Doxorubicin—sarcoma	0.000728	0.000943	CcSEcCtD
Acamprosate—Headache—Vincristine—sarcoma	0.000726	0.000941	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—sarcoma	0.00072	0.000933	CcSEcCtD
Acamprosate—Vomiting—Mitoxantrone—sarcoma	0.000717	0.00093	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000716	0.00313	CbGpPWpGaD
Acamprosate—Visual impairment—Epirubicin—sarcoma	0.000714	0.000925	CcSEcCtD
Acamprosate—Rash—Mitoxantrone—sarcoma	0.000711	0.000922	CcSEcCtD
Acamprosate—Dermatitis—Mitoxantrone—sarcoma	0.000711	0.000921	CcSEcCtD
Acamprosate—Headache—Mitoxantrone—sarcoma	0.000707	0.000916	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCR4—sarcoma	0.000703	0.00308	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000695	0.00304	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—SRC—sarcoma	0.000693	0.00303	CbGpPWpGaD
Acamprosate—Hypersensitivity—Etoposide—sarcoma	0.000692	0.000896	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—sarcoma	0.00069	0.000895	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—sarcoma	0.000689	0.000893	CcSEcCtD
Acamprosate—Nausea—Vincristine—sarcoma	0.000688	0.000892	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—sarcoma	0.000687	0.00089	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—sarcoma	0.000685	0.000888	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—sarcoma	0.000685	0.000888	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—sarcoma	0.000682	0.000884	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—sarcoma	0.00068	0.000881	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MDM2—sarcoma	0.000678	0.00297	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CREB1—sarcoma	0.000675	0.00296	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—SRC—sarcoma	0.000675	0.00296	CbGpPWpGaD
Acamprosate—Oedema peripheral—Doxorubicin—sarcoma	0.000675	0.000875	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—sarcoma	0.000675	0.00295	CbGpPWpGaD
Acamprosate—Asthenia—Etoposide—sarcoma	0.000673	0.000873	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CREB1—sarcoma	0.000673	0.00295	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—sarcoma	0.000672	0.00294	CbGpPWpGaD
Acamprosate—Nausea—Mitoxantrone—sarcoma	0.00067	0.000869	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—sarcoma	0.000669	0.000867	CcSEcCtD
Acamprosate—Chills—Epirubicin—sarcoma	0.000664	0.000861	CcSEcCtD
Acamprosate—Pruritus—Etoposide—sarcoma	0.000664	0.000861	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—sarcoma	0.000662	0.0029	CbGpPWpGaD
Acamprosate—Visual impairment—Doxorubicin—sarcoma	0.00066	0.000856	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—sarcoma	0.000658	0.00288	CbGpPWpGaD
Acamprosate—Alopecia—Epirubicin—sarcoma	0.000654	0.000848	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—TLE1—sarcoma	0.000652	0.00285	CbGpPWpGaD
Acamprosate—Mental disorder—Epirubicin—sarcoma	0.000649	0.000841	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000646	0.00283	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CCND1—sarcoma	0.000645	0.00282	CbGpPWpGaD
Acamprosate—Malnutrition—Epirubicin—sarcoma	0.000645	0.000836	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—sarcoma	0.000642	0.000832	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—sarcoma	0.000639	0.000828	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—sarcoma	0.000635	0.000823	CcSEcCtD
Acamprosate—Tension—Epirubicin—sarcoma	0.000633	0.00082	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—sarcoma	0.000631	0.000818	CcSEcCtD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.00063	0.00276	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CREB1—sarcoma	0.000628	0.00275	CbGpPWpGaD
Acamprosate—Nervousness—Epirubicin—sarcoma	0.000626	0.000812	CcSEcCtD
Acamprosate—Back pain—Epirubicin—sarcoma	0.000624	0.000808	CcSEcCtD
Acamprosate—Dizziness—Etoposide—sarcoma	0.000621	0.000804	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—sarcoma	0.00062	0.000803	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—sarcoma	0.000619	0.000802	CcSEcCtD
Acamprosate—Chills—Doxorubicin—sarcoma	0.000615	0.000797	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—sarcoma	0.000605	0.000785	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—sarcoma	0.0006	0.000778	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—sarcoma	0.000598	0.000775	CcSEcCtD
Acamprosate—Vomiting—Etoposide—sarcoma	0.000597	0.000773	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—sarcoma	0.000596	0.000773	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—sarcoma	0.000596	0.000772	CcSEcCtD
Acamprosate—Agitation—Epirubicin—sarcoma	0.000592	0.000768	CcSEcCtD
Acamprosate—Rash—Etoposide—sarcoma	0.000592	0.000767	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—sarcoma	0.000591	0.000766	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.00059	0.00258	CbGpPWpGaD
Acamprosate—Headache—Etoposide—sarcoma	0.000588	0.000762	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—sarcoma	0.000588	0.000762	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000587	0.00257	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—sarcoma	0.000586	0.00256	CbGpPWpGaD
Acamprosate—Tension—Doxorubicin—sarcoma	0.000585	0.000759	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—sarcoma	0.000584	0.000757	CcSEcCtD
Acamprosate—Malaise—Epirubicin—sarcoma	0.000581	0.000753	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—sarcoma	0.000579	0.000751	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—sarcoma	0.000579	0.000751	CcSEcCtD
Acamprosate—Syncope—Epirubicin—sarcoma	0.000578	0.000749	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—sarcoma	0.000577	0.000748	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—sarcoma	0.000577	0.000748	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—sarcoma	0.000573	0.000743	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CREB1—sarcoma	0.000572	0.0025	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—sarcoma	0.000571	0.0025	CbGpPWpGaD
Acamprosate—Palpitations—Epirubicin—sarcoma	0.00057	0.000738	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—sarcoma	0.000567	0.000734	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PTPRC—sarcoma	0.000565	0.00247	CbGpPWpGaD
Acamprosate—Cough—Epirubicin—sarcoma	0.000563	0.000729	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—MDM2—sarcoma	0.000559	0.00245	CbGpPWpGaD
Acamprosate—Convulsion—Epirubicin—sarcoma	0.000559	0.000724	CcSEcCtD
Acamprosate—Nausea—Etoposide—sarcoma	0.000558	0.000723	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MDM2—sarcoma	0.000557	0.00244	CbGpPWpGaD
Acamprosate—Hypertension—Epirubicin—sarcoma	0.000557	0.000721	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—sarcoma	0.000553	0.000717	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PLCG1—sarcoma	0.000553	0.00242	CbGpPWpGaD
Acamprosate—Anaemia—Doxorubicin—sarcoma	0.000551	0.000715	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PTPRC—sarcoma	0.000551	0.00241	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFC—sarcoma	0.00055	0.00241	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—JUN—sarcoma	0.000549	0.0024	CbGpPWpGaD
Acamprosate—Myalgia—Epirubicin—sarcoma	0.000549	0.000711	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—sarcoma	0.000549	0.000711	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—sarcoma	0.000549	0.000711	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—sarcoma	0.000548	0.00071	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—sarcoma	0.000547	0.000709	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000545	0.000706	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—CTNNB1—sarcoma	0.000545	0.00238	CbGpPWpGaD
Acamprosate—Discomfort—Epirubicin—sarcoma	0.000542	0.000703	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PLCG1—sarcoma	0.000539	0.00236	CbGpPWpGaD
Acamprosate—Malaise—Doxorubicin—sarcoma	0.000538	0.000697	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—sarcoma	0.000537	0.000696	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—sarcoma	0.000536	0.000695	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—JUN—sarcoma	0.000535	0.00234	CbGpPWpGaD
Acamprosate—Syncope—Doxorubicin—sarcoma	0.000535	0.000693	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—sarcoma	0.000534	0.000692	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000532	0.00233	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CTNNB1—sarcoma	0.000531	0.00232	CbGpPWpGaD
Acamprosate—Confusional state—Epirubicin—sarcoma	0.00053	0.000688	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—sarcoma	0.000527	0.000683	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—sarcoma	0.000526	0.000682	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—sarcoma	0.000524	0.00068	CcSEcCtD
Acamprosate—Infection—Epirubicin—sarcoma	0.000523	0.000677	CcSEcCtD
Acamprosate—Cough—Doxorubicin—sarcoma	0.000521	0.000675	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—MDM2—sarcoma	0.00052	0.00227	CbGpPWpGaD
Acamprosate—Shock—Epirubicin—sarcoma	0.000518	0.000671	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—sarcoma	0.000518	0.00227	CbGpPWpGaD
Acamprosate—Convulsion—Doxorubicin—sarcoma	0.000517	0.00067	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—CREB1—sarcoma	0.000516	0.00226	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000515	0.00225	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Epirubicin—sarcoma	0.000515	0.000668	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000515	0.00225	CbGpPWpGaD
Acamprosate—Hypertension—Doxorubicin—sarcoma	0.000515	0.000667	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—sarcoma	0.000513	0.000666	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000511	0.00224	CbGpPWpGaD
Acamprosate—Skin disorder—Epirubicin—sarcoma	0.000511	0.000662	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—sarcoma	0.000509	0.000659	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—sarcoma	0.000508	0.000658	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—sarcoma	0.000508	0.000658	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—sarcoma	0.000508	0.000658	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—sarcoma	0.000506	0.00222	CbGpPWpGaD
Acamprosate—Anxiety—Doxorubicin—sarcoma	0.000506	0.000656	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000506	0.00221	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000504	0.000654	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CREB1—sarcoma	0.000504	0.0022	CbGpPWpGaD
Acamprosate—Discomfort—Doxorubicin—sarcoma	0.000502	0.00065	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—sarcoma	0.000502	0.00065	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—sarcoma	0.000497	0.000644	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000495	0.00217	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—SRC—sarcoma	0.000492	0.00216	CbGpPWpGaD
Acamprosate—Hypotension—Epirubicin—sarcoma	0.000492	0.000637	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—sarcoma	0.000491	0.000636	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—sarcoma	0.000488	0.00213	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Doxorubicin—sarcoma	0.000487	0.000631	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000486	0.00213	CbGpPWpGaD
Acamprosate—Infection—Doxorubicin—sarcoma	0.000484	0.000627	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—SRC—sarcoma	0.00048	0.0021	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000479	0.000621	CcSEcCtD
Acamprosate—Shock—Doxorubicin—sarcoma	0.000479	0.000621	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—sarcoma	0.000477	0.000618	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—sarcoma	0.000476	0.000617	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—sarcoma	0.000475	0.00208	CbGpPWpGaD
Acamprosate—Tachycardia—Doxorubicin—sarcoma	0.000475	0.000616	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MDM2—sarcoma	0.000473	0.00207	CbGpPWpGaD
Acamprosate—Skin disorder—Doxorubicin—sarcoma	0.000473	0.000613	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—sarcoma	0.000472	0.000612	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—sarcoma	0.000471	0.00061	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—sarcoma	0.000469	0.000608	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—sarcoma	0.000468	0.000606	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—sarcoma	0.000464	0.000601	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—sarcoma	0.000463	0.0006	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—sarcoma	0.000457	0.000593	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—KDR—sarcoma	0.000455	0.00199	CbGpPWpGaD
Acamprosate—Hypotension—Doxorubicin—sarcoma	0.000455	0.00059	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—sarcoma	0.000454	0.000589	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00045	0.00197	CbGpPWpGaD
Acamprosate—Constipation—Epirubicin—sarcoma	0.00045	0.000583	CcSEcCtD
Acamprosate—Pain—Epirubicin—sarcoma	0.00045	0.000583	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—CREB1—sarcoma	0.00045	0.00197	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—sarcoma	0.000444	0.00194	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000444	0.000575	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000442	0.00194	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—sarcoma	0.00044	0.000571	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FLT1—sarcoma	0.00044	0.00192	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CREB1—sarcoma	0.000438	0.00192	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—sarcoma	0.000437	0.000567	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—sarcoma	0.000434	0.000563	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—sarcoma	0.000434	0.000562	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—sarcoma	0.000433	0.000561	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PLCG1—sarcoma	0.000432	0.00189	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Epirubicin—sarcoma	0.00043	0.000558	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—sarcoma	0.000429	0.000555	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—MDM2—sarcoma	0.000427	0.00187	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000426	0.00187	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—sarcoma	0.000425	0.00186	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—sarcoma	0.000423	0.000548	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00042	0.000545	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000419	0.00183	CbGpPWpGaD
Acamprosate—Urticaria—Epirubicin—sarcoma	0.000418	0.000542	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—sarcoma	0.000416	0.00054	CcSEcCtD
Acamprosate—Pain—Doxorubicin—sarcoma	0.000416	0.00054	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—sarcoma	0.000416	0.000539	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—sarcoma	0.000416	0.000539	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CXCR4—sarcoma	0.000415	0.00182	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ATF1—sarcoma	0.00041	0.0018	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000406	0.00178	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000405	0.00177	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—sarcoma	0.000401	0.00052	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—sarcoma	0.0004	0.00175	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CREB1—sarcoma	0.000399	0.00175	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000398	0.000516	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—FOXO1—sarcoma	0.000393	0.00172	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CREB1—sarcoma	0.000389	0.0017	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—sarcoma	0.000388	0.000502	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CREB1—sarcoma	0.000387	0.0017	CbGpPWpGaD
Acamprosate—Urticaria—Doxorubicin—sarcoma	0.000387	0.000501	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—sarcoma	0.000385	0.000499	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—sarcoma	0.000385	0.000499	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—FOXO1—sarcoma	0.000383	0.00168	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CREB1—sarcoma	0.00038	0.00166	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—sarcoma	0.000377	0.000489	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CREB1—sarcoma	0.000376	0.00165	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—sarcoma	0.000372	0.000482	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—MDM2—sarcoma	0.000372	0.00163	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—sarcoma	0.000372	0.00163	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—sarcoma	0.000371	0.00163	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000366	0.0016	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MDM2—sarcoma	0.000363	0.00159	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—sarcoma	0.000362	0.00159	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—sarcoma	0.000362	0.00159	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—sarcoma	0.00036	0.000467	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—sarcoma	0.000359	0.00157	CbGpPWpGaD
Acamprosate—Hypersensitivity—Doxorubicin—sarcoma	0.000359	0.000465	CcSEcCtD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000355	0.00155	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—sarcoma	0.000349	0.000453	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—sarcoma	0.000348	0.000451	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—sarcoma	0.000347	0.00152	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000346	0.00151	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—sarcoma	0.000344	0.000446	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—sarcoma	0.000338	0.00148	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—sarcoma	0.000335	0.000434	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—sarcoma	0.000333	0.000432	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000332	0.00145	CbGpPWpGaD
Acamprosate—Rash—Epirubicin—sarcoma	0.000332	0.00043	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—sarcoma	0.000331	0.00043	CcSEcCtD
Acamprosate—Headache—Epirubicin—sarcoma	0.00033	0.000427	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—sarcoma	0.000325	0.00142	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—sarcoma	0.000325	0.00142	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—sarcoma	0.000322	0.00141	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—sarcoma	0.000322	0.000417	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—sarcoma	0.00032	0.0014	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—sarcoma	0.000317	0.00139	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000315	0.00138	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—sarcoma	0.000313	0.000405	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—sarcoma	0.00031	0.000401	CcSEcCtD
Acamprosate—Rash—Doxorubicin—sarcoma	0.000307	0.000398	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—sarcoma	0.000307	0.000397	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—HRAS—sarcoma	0.000307	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FOXO1—sarcoma	0.000307	0.00134	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—sarcoma	0.000306	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFRB—sarcoma	0.000306	0.00134	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—sarcoma	0.000306	0.00134	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—sarcoma	0.000305	0.000395	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDGFRA—sarcoma	0.000301	0.00132	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CREB1—sarcoma	0.000297	0.0013	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000292	0.00128	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CREB1—sarcoma	0.000291	0.00128	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000289	0.00127	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—sarcoma	0.000289	0.000375	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—HRAS—sarcoma	0.000285	0.00125	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CREB1—sarcoma	0.000285	0.00125	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—sarcoma	0.000278	0.00122	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CREB1—sarcoma	0.000278	0.00122	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000275	0.0012	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000267	0.00117	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—sarcoma	0.000265	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—sarcoma	0.00026	0.00114	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—sarcoma	0.000258	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—sarcoma	0.000257	0.00113	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000255	0.00112	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CREB1—sarcoma	0.000255	0.00111	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—sarcoma	0.000254	0.00111	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—sarcoma	0.000251	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—sarcoma	0.000251	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NRAS—sarcoma	0.000248	0.00108	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MDM2—sarcoma	0.000245	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—sarcoma	0.000244	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NRAS—sarcoma	0.000241	0.00106	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—sarcoma	0.000241	0.00106	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—sarcoma	0.000234	0.00102	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000234	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—sarcoma	0.000234	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—sarcoma	0.000234	0.00102	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.00023	0.00101	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—sarcoma	0.000229	0.001	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—sarcoma	0.000226	0.000988	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CREB1—sarcoma	0.000222	0.000973	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—sarcoma	0.00022	0.000963	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—sarcoma	0.000213	0.000933	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—sarcoma	0.000213	0.000931	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MDM2—sarcoma	0.000211	0.000922	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—sarcoma	0.000208	0.000909	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—sarcoma	0.000204	0.000894	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—sarcoma	0.000203	0.00089	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—sarcoma	0.000201	0.00088	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000201	0.000879	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—sarcoma	0.000199	0.000871	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—sarcoma	0.000198	0.000867	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—sarcoma	0.000184	0.000805	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—sarcoma	0.000184	0.000804	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—sarcoma	0.000181	0.000793	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—sarcoma	0.000179	0.000784	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—sarcoma	0.000179	0.000783	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—sarcoma	0.000177	0.000774	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—sarcoma	0.000177	0.000773	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—sarcoma	0.000176	0.00077	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—sarcoma	0.000174	0.000763	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000173	0.000756	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—sarcoma	0.000172	0.000754	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—sarcoma	0.000171	0.000748	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—sarcoma	0.000164	0.000719	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—sarcoma	0.000161	0.000705	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—sarcoma	0.00016	0.000701	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—sarcoma	0.00016	0.0007	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—sarcoma	0.000159	0.000695	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—sarcoma	0.000157	0.000687	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—sarcoma	0.000152	0.000666	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000151	0.000661	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—sarcoma	0.000148	0.000649	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—sarcoma	0.000143	0.000628	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—sarcoma	0.00014	0.000611	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—sarcoma	0.000138	0.000604	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—sarcoma	0.000135	0.00059	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—sarcoma	0.000132	0.000579	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—sarcoma	0.000129	0.000566	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—sarcoma	0.000129	0.000563	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—sarcoma	0.000126	0.000552	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—sarcoma	0.000126	0.00055	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—sarcoma	0.000119	0.00052	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—sarcoma	0.000116	0.000506	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—sarcoma	0.000106	0.000462	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—sarcoma	0.000101	0.000442	CbGpPWpGaD
